PMV Pharmaceuticals
PMVP | NASDAQ
$1.19
-$0.08 (-6.30%)
At close: Nov 16, 2026, 4:00 PM ET
$1.20
+$0.01 (+0.84%)
After-hours:
Nov 16, 2026, 7:09 PM ET
-6.30%
(1D)No price chart data available for 1D timeframe.
Rating
23.8
Fundamentals Weak
Market Sentiment Neutral
Moat None
Sector Rank #953/1021 (Top 93%)
Key Statistics
Market Data
Market Cap $78.81M
1D Range
1.18 1.30
52W Range
1.02 1.80
Valuation (TTM)
PE -0.77
PB 1.38
EV/EBITDA 0.32
Valuation (NTM)
Forward PE N/A
Forward PEG 0.06
Price Target $5.00
Cash Flow
FCF Yield -88.4%
SBC Adj. FCF Yield -95.9%
SBC Impact -8.5%
Margins
Gross Margin 0.0%
Operating Margin 0.0%
FCF Margin N/A
Growth (CAGR)
Revenue 3Y | 5Y N/A |
N/A
Dil EPS 3Y | 5Y -19.6% |
0.6%
FCF 3Y | 5Y -17.5% |
-2.7%
Returns
ROA -79.5%
ROE -110.2%
ROIC -76.5%
Financial Health
Net Cash
$102.56M
Current Ratio 9.81
Interest Coverage 0.00
Dividends
Div Yield N/A
Payout Ratio N/A
FCF Payout Ratio N/A
Loading financial charts...
Profile
PMV Pharmaceuticals, Inc. operates as a precision oncology company focused on discovering and developing both small molecule and tumor-agnostic therapies to address p53 mutations in cancer patients. T...
Sector Healthcare
Industry Biotechnology
Employees 54
IPO Date Sep 25, 2020
Website www.pmvpharma.com
Fiscal Year January - December
Latest News
No news articles available yet.
Analyst Summary
# of Analysts
2
Consensus
Buy
Price Target
$5.00
Upside
+320.17%
Buy (2)
Hold (0)
Sell (0)
Add to Watchlist
Select watchlists to add or remove PMVP